223 related articles for article (PubMed ID: 30773806)
1. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
[TBL] [Abstract][Full Text] [Related]
2. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.
Manji F; Warkentin TE; Sheppard JI; Lee A
Platelets; 2020; 31(1):124-127. PubMed ID: 31397594
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.
Warkentin TE
Expert Rev Hematol; 2019 Aug; 12(8):685-698. PubMed ID: 31274032
[No Abstract] [Full Text] [Related]
5. Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.
Poudel DR; Ghimire S; Dhital R; Forman DA; Warkentin TE
Platelets; 2017 Sep; 28(6):614-620. PubMed ID: 28856946
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
Dougherty JA; Yarsley RL
Ann Pharmacother; 2021 Feb; 55(2):198-215. PubMed ID: 32693627
[TBL] [Abstract][Full Text] [Related]
7. Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty.
Hwang SR; Wang Y; Weil EL; Padmanabhan A; Warkentin TE; Pruthi RK
Platelets; 2021 Oct; 32(7):936-940. PubMed ID: 33000657
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune heparin-induced thrombocytopenia.
Greinacher A; Selleng K; Warkentin TE
J Thromb Haemost; 2017 Nov; 15(11):2099-2114. PubMed ID: 28846826
[TBL] [Abstract][Full Text] [Related]
9. Early high-dose intravenous immunoglobulin for refractory heparin-induced thrombocytopenia with stroke: Two case reports.
Makita N; Ohara T; Tsuji Y; Ueda T; Nakamura T; Mizuno T; Makino M
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107032. PubMed ID: 36701852
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Begelman SM; Hursting MJ; Aghababian RV; McCollum D
J Intern Med; 2005 Dec; 258(6):563-72. PubMed ID: 16313480
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune heparin-induced thrombocytopenia and venous limb gangrene after aortic dissection repair: in vitro and in vivo effects of intravenous immunoglobulin.
Arcinas LA; Manji RA; Hrymak C; Dao V; Sheppard JI; Warkentin TE
Transfusion; 2019 Jun; 59(6):1924-1933. PubMed ID: 30903805
[TBL] [Abstract][Full Text] [Related]
12. Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.
Irani M; Siegal E; Jella A; Aster R; Padmanabhan A
Transfusion; 2019 Mar; 59(3):931-934. PubMed ID: 30556588
[TBL] [Abstract][Full Text] [Related]
13. Inpatient management strategies in a severe case of heparin-induced thrombocytopenia.
Shmookler AD; Arays R; McCarthy P
Transfus Apher Sci; 2019 Aug; 58(4):525-528. PubMed ID: 31327731
[TBL] [Abstract][Full Text] [Related]
14. Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case report.
Lei BZ; Shatzel JJ; Sendowski M
Transfusion; 2017 Apr; 57(4):919-923. PubMed ID: 27943368
[TBL] [Abstract][Full Text] [Related]
15. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Hursting MJ; Levine RL; Leya F
Chest; 2006 Jun; 129(6):1407-16. PubMed ID: 16778256
[TBL] [Abstract][Full Text] [Related]
16. Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
Wang Y; Zhang K; Yin L; Fu G; Liu Z
Ann Vasc Surg; 2022 Mar; 80():392.e1-392.e7. PubMed ID: 34656708
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia.
Aryal MR; Gosain R; Donato A; Katel A; Chakradhar R; Dhital R; Kouides PA
Blood Coagul Fibrinolysis; 2020 Jul; 31(5):287-292. PubMed ID: 32398463
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
Murray PT; Hursting MJ
Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
[TBL] [Abstract][Full Text] [Related]
19. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
Cuker A; Arepally GM; Chong BH; Cines DB; Greinacher A; Gruel Y; Linkins LA; Rodner SB; Selleng S; Warkentin TE; Wex A; Mustafa RA; Morgan RL; Santesso N
Blood Adv; 2018 Nov; 2(22):3360-3392. PubMed ID: 30482768
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series.
Lai CMB; Smith T; Lee AYY
J Thromb Thrombolysis; 2021 Apr; 51(3):725-733. PubMed ID: 33582956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
